Fatty Acid Synthase
Fatty Acid Synthase (FAS) is a multi-enzyme complex responsible for the synthesis of long-chain fatty acids. Overexpression of FAS is associated with various metabolic disorders, including obesity, diabetes, and cancer. Inhibiting FAS can reduce lipid biosynthesis and induce apoptosis in cancer cells, making it a promising target for cancer therapy and metabolic disease research. At CymitQuimica, we provide a variety of FAS inhibitors to support your research in oncology, metabolism, and therapeutic development.
Found 32 products of "Fatty Acid Synthase"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
FASN-IN-3
CAS:<p>FASN-IN-3 is an inhibitor of fatty acid synthase (FASN).</p>Formula:C24H24N4OPurity:97.41%Color and Shape:SolidMolecular weight:384.47Denifanstat
CAS:<p>Denifanstat (FASN-IN-2) is a FASN inhibitor with selective and oral activity. Denifanstat has been used in studies of steatohepatitis. Cost effective and quality assured.</p>Formula:C27H29N5OPurity:98.33% - 99.35%Color and Shape:SolidMolecular weight:439.55PF429242 dihydrochloride
CAS:<p>PF429242 dihydrochloride can reversibly inhibit S1P (IC50 of 175 nM).</p>Formula:C25H37Cl2N3O2Purity:99.68%Color and Shape:SolidMolecular weight:482.49trans-C75
CAS:<p>trans-C75 ((±)-C75) is an enantiomer of C75. C75 is an inhibitor of fatty-acid synthase (FASN).</p>Formula:C14H22O4Purity:98.88% - 99.57%Color and Shape:White To Off-White SolidMolecular weight:254.32CTL-12
<p>CTL-12, a fatty acid synthase (FASN) inhibitor (IC50: 2.5 μM), induces apoptosis and disrupts the cell cycle at the Sub-G1/S phase.</p>Formula:C22H21ClN4O4Color and Shape:SolidMolecular weight:440.88Betulin ditosylate
CAS:<p>Betulinditosylate is a derivative of Betulin, which functions as an SREBP inhibitor.</p>Formula:C44H62O6S2Color and Shape:SolidMolecular weight:751.09IPI-9119
CAS:<p>IPI-9119 is an orally active, selective and irreversible FASN inhibitor (IC50 = 0.3 nM).</p>Formula:C24H19F2N5O5Purity:99.81%Color and Shape:SolidMolecular weight:495.43FASN-IN-4 tosylate
CAS:<p>FASN-IN-4 tosylate: Fatty acid synthase inhibitor, IC50 10 nM; blocks SARS-CoV-2, EC50 18.6 nM.</p>Formula:C33H35N3O7S2Color and Shape:SolidMolecular weight:649.78Fasnall HCl
<p>Fasnall HCl is a selective FASN inhibitor that acts through its co-factor binding sites.</p>Formula:C19H23ClN4SPurity:99.9%Color and Shape:SoildMolecular weight:374.93CTL-06
<p>CTL-06, a Fatty Acid Synthase (FASN) inhibitor with an IC50 of 3 μM, induces apoptosis, while CTL-12 impedes cell cycle progression in the Sub-G1/S phase and</p>Formula:C21H21ClN4O4Color and Shape:SolidMolecular weight:428.87ACSS2-IN-2
CAS:<p>MTB-9655 inhibits ACSS2 with 3.8 nM IC50, useful in research of viral, metabolic, neuropsychiatric diseases, inflammation, and cancer.</p>Formula:C21H19F2N3O4Purity:99.5%Color and Shape:SoildMolecular weight:415.39Lipid Metabolism Compound Library
<p>A unique collection of 492 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).</p>Color and Shape:Odour SolidFASN Protein, Human, Recombinant (His)
<p>FASN Protein, Human, Recombinant (His) is expressed in E.</p>Color and Shape:Lyophilized PowderMolecular weight:35.26 kDa (predicted)Anti-FASN Antibody (6U56)
<p>Anti-FASN Antibody (6U56) is an antibody targeting FASN. Anti-FASN Antibody (6U56) can be used in ELISA, IF, FCM.</p>Color and Shape:Odour LiquidBI 99179
CAS:<p>BI 99179 is a selective and potent inhibitor of type I fatty acid synthase (FAS), a tool compound for targeting FAS for cancer research.</p>Formula:C23H25N3O3Purity:98.73%Color and Shape:SolidMolecular weight:391.46FASN Protein, Mouse, Recombinant (His)
<p>FASN Protein, Mouse, Recombinant (His) is expressed in E.</p>Purity:≥ 95 % as determined by SDS-PAGE. - ≥ 95 % as determined by SDS-PAGE.Color and Shape:Lyophilized PowderMolecular weight:34.23 kDa (predicted)VY-3-135
CAS:<p>VY-3-135 is an orally active, stable and specific acetyl-CoA synthetase 2 (ACSS2) inhibitor.Cost-effective and quality-assured.</p>Formula:C26H27N3O3Purity:99.25% - 99.79%Color and Shape:SolidMolecular weight:429.51FT113
CAS:<p>FT113 is a novel potent inhibitor of fatty acid synthase (fasn, IC50 : 213 nM),and exhibits anti-cancer activity</p>Formula:C22H20FN3O4Purity:97.05%Color and Shape:SolidMolecular weight:409.41TVB-3664
CAS:<p>TVB-3664 is an orally active, selective, highly bioavailable fatty acid synthase inhibitor (FASN).Cost-effective and quality-assured.</p>Formula:C25H23F3N4O2Purity:99.17% - 99.64%Color and Shape:SolidMolecular weight:468.47PF 429242
CAS:<p>PF-429242 inhibits SREBP site 1 protease selectively (IC50: 0.175 μM); reduces cholesterol synthesis in CHO cells (IC50: 0.53 μM).</p>Formula:C25H35N3O2Purity:99.27%Color and Shape:SolidMolecular weight:409.56Fas C-Terminal Tripeptide Acetate
<p>Fas C-Terminal Tripeptide Acetate shows inhibitory activity of Fas/FAP-1 binding.</p>Formula:C18H33N3O8Purity:99.12%Color and Shape:SolidMolecular weight:419.47HS79
CAS:<p>HS-79, a Fasnall enantiomer, selectively inhibits FASN with an IC50 of 1.57 μM, blocking tritiated acetate lipid incorporation.</p>Formula:C19H22N4SPurity:98%Color and Shape:SolidMolecular weight:338.47HS80
CAS:<p>HS-80, a Fasnall enantiomer, selectively inhibits FASN, blocking lipid synthesis (IC50: 7.13 μM).</p>Formula:C19H22N4SPurity:98%Color and Shape:SolidMolecular weight:338.47FASN-IN-5
CAS:<p>FASN-IN-5 is a FASN inhibitor, useful for studying cancer and metabolic diseases.</p>Formula:C29H26N4O2Purity:99.88%Color and Shape:SolidMolecular weight:462.54FASN-IN-4
CAS:<p>FAS-IN-1 is a potent inhibitor of Fatty acid synthase (FAS) wtih IC50 of 10 nM.</p>Formula:C26H27N3O4SPurity:98%Color and Shape:SolidMolecular weight:477.58C75
CAS:<p>C75 is an inhibitor synthetic fatty-acid synthase (FASN) and inhibits prostate cancer cells PC3 (IC50: 35 μM).</p>Formula:C14H22O4Purity:98.84% - >99.99%Color and Shape:SolidMolecular weight:254.32Malic enzyme inhibitor ME1
CAS:<p>Malic enzyme inhibitor ME1 (ME1) is a specific inhibitor of Malic enzyme (IC50 = 0.15 μM). Malic enzyme inhibitor ME1 reduces cell viability/metabolic activity.</p>Formula:C20H21N3O3Purity:99.84%Color and Shape:SolidMolecular weight:351.4FASN-IN-1
CAS:<p>FASN-in-1 is an effective, specific inhibitor of fatty acid synthase (FASN), a compound specifically designed to target and inhibit the activity of the enzyme</p>Formula:C18H25N3O3S2Purity:99.92% - >99.99%Color and Shape:SolidMolecular weight:395.54SREBP/SCAP-IN-2
CAS:<p>SREBP/SCAP-IN-2 (compound 13) acts as a selective inhibitor of SREBP/SCAP [1].</p>Formula:C27H37ClF2N4OColor and Shape:SolidMolecular weight:507.06SREBP/SCAP-IN-1
CAS:<p>SREBP/SCAP-IN-1 (compound 10b) serves as a selective inhibitor of SREBP/SCAP [1].</p>Formula:C28H40F2N4OColor and Shape:SolidMolecular weight:486.64FAS-IN-1 Tosylate
<p>FAS-IN-1 Tosylate is an effective fatty acid synthase inhibitor;Has an IC50 of 10 nM.</p>Formula:C33H35N3O7S2Purity:98%Color and Shape:SolidMolecular weight:649.78PFM046
CAS:<p>PFM046 is an antagonist of the liver X receptor (LXR), effectively inhibiting the activation of LXRα and LXRβ, with IC50 values of 2.04 μM and 1.58 μM respectively. It reduces the expression of SCD1 and FASN while increasing ABCA1 expression, and demonstrates antitumor activity in mouse models.</p>Formula:C29H42O2Color and Shape:SolidMolecular weight:422.643
